Haddish will Emcee the Event in Washington, DC on November 10 WASHINGTON, Oct. 31, 2024 /PRNewswire/ — Award-winning comedian and actress Tiffany Haddish has been announced as emcee of Stand Together – an event of Jewish Unity, Strength, and Resilience. Haddish is an Emmy- and…
Month: October 2024
TIFFANY HADDISH, IDAN RAICHEL, FIVE FOR FIGHTING TO HEADLINE STAND TOGETHER
Haddish will Emcee the Event in Washington, DC on November 10 WASHINGTON, Oct. 31, 2024 /PRNewswire/ — Award-winning comedian and actress Tiffany Haddish has been announced as emcee of Stand Together – an event of Jewish Unity, Strength, and Resilience. Haddish is an Emmy- and…
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand…
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand…
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand…
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand…
Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million
VICTORIA, BC, Oct. 31, 2024 /PRNewswire/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet…
Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million
VICTORIA, BC, Oct. 31, 2024 /PRNewswire/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet…
TEAMSTERS BOYCOTT BIGFOOT BEVERAGES
Union Calls on Oregonians to Join the Fight as Strike Enters Seventh Week EUGENE, Ore., Oct. 31, 2024 /PRNewswire/ — Teamsters Local 206 and 324 are calling for Oregon residents to boycott Bigfoot Beverages, one of the largest soft drink and alcohol distributors in the state. Members of…
TEAMSTERS BOYCOTT BIGFOOT BEVERAGES
Union Calls on Oregonians to Join the Fight as Strike Enters Seventh Week EUGENE, Ore., Oct. 31, 2024 /PRNewswire/ — Teamsters Local 206 and 324 are calling for Oregon residents to boycott Bigfoot Beverages, one of the largest soft drink and alcohol distributors in the state. Members of…
